Robert Chang

Robert Chang has extensive experience in the pharmaceutical and biotechnology industry, focusing on quality assurance, clinical processes, process improvement, and risk management. ROBERT has held roles at companies such as HUTCHMED, IQVIA, Acorda Therapeutics, Inc., Eisai, and Johnson & Johnson/Janssen Pharmaceuticals. Their responsibilities have included driving clinical quality, managing quality issues and deviations, and developing risk-based approaches for clinical trials/studies. Robert has also provided consulting services to enhance quality, compliance, and operational excellence in various organizations. Their expertise includes risk assessment, process development, and process reengineering.

Robert Chang holds a Bachelor of Science in Chemical Engineering from Cornell University and an MBA from The Wharton School, with a focus on Finance and a minor in Decision Sciences. ROBERT also obtained a certification as a Certified Six Sigma Black Belt from The Janssen Pharmaceutical Companies of Johnson & Johnson.